We found that SLC17A9 expression in PCa patients with ERG fusion status and AR amplification status was decreased, manifesting downregulated SLC17A9 expression in PCa patients with ERG fusion status and AR amplification status. This evidence concerns the gene SLC17A9 and posterior cortical atrophy.